Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…
← Endocrinology and metabolism indexChapter sections
Role and principlesAssessment and patient selectionBaseline assessmentInterventionsTargets, monitoring and follow-upSpecial situationsCommon pitfallsQuestionsSources
Full textbook9 sectionsOpen only what you need
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.

Obesity assessment and behavioural treatment

Endocrinology and metabolism · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Time-critical presentation

Weight itself is not an emergency diagnosis. Escalate acute obesity-hypoventilation decompensation, chest pain, severe hypertension with organ injury, hyperglycaemic crisis, suicidal crisis, eating-disorder medical instability or a safeguarding concern through the relevant emergency pathway rather than delaying care for weight counselling.

Role and principles

Assess adiposity and its health effects without stigma, identify treatable drivers and complications, and build a sustainable multicomponent plan around the person's priorities and circumstances.

Obesity is a chronic, relapsing condition shaped by neuroendocrine regulation, genetics, medicines, environment, social determinants and behaviour. A respectful consultation improves disclosure and follow-up; moral judgement does not. Begin by asking whether weight is a topic the person wants to address today and whether being weighed is acceptable and safe.

Assessment has two linked aims: estimate adiposity-related risk and identify what is already affecting health. BMI categories help population decisions, while waist distribution, comorbidity and function refine individual risk. Muscular people, frail older adults, people with oedema, pregnancy and some disabilities need interpretation outside a mechanical BMI label.

A behavioural programme should create a feasible energy deficit without nutritional inadequacy, support movement within pain and disability limits, and build routines that can persist after intensive contact ends. No single named diet is universally superior. Cultural food patterns, finances, cooking access, caring duties, medication, sleep and the risk of eating-disorder relapse determine what is safe and sustainable.

Key points

  • Ask permission to discuss weight, use the person's preferred language and offer a private, accessible weighing environment with suitable calibrated equipment.
  • BMI is a screening measure, not a direct measure of individual health, muscle, fat distribution, disability, ethnicity, pregnancy or lived experience.
  • For adults with BMI below 35, waist-to-height ratio can add central-adiposity information; a waist less than half height is a simple population message.
  • NICE advises lower BMI thresholds, usually by 2.5 kg/m², when assessing intervention eligibility for several ethnic groups who develop cardiometabolic risk at lower BMI.
  • Assess consequences systematically: type 2 diabetes, blood pressure, lipids, cardiovascular disease, sleep apnoea, fatty-liver risk, osteoarthritis, reproductive health and mental wellbeing.
  • Look for medicine-related weight gain, sleep disruption, food insecurity, pain, shift work, menopause, neurodivergence, disability and disordered eating before prescribing a generic plan.
  • Routine endocrine screening beyond clinically indicated thyroid or cortisol assessment has low yield; targeted clues should drive secondary-cause testing.
  • Behavioural treatment works best as an individualised package covering dietary quality and energy balance, activity, sleep, self-monitoring, problem-solving and social context.

Assessment and patient selection

Central adiposity

A high waist-to-height ratio suggests visceral fat and cardiometabolic risk even when BMI is below an obesity threshold; use it as an additional conversation, not a diagnosis of character.

Established metabolic complication

Raised blood pressure, dysglycaemia, atherogenic lipids or steatotic-liver risk increases treatment priority and may improve with modest sustained loss, independent of reaching a culturally idealised weight.

Sleep-related breathing diseaseRed flag

Loud snoring, witnessed apnoeas, morning headache, unrefreshing sleep and daytime somnolence suggest obstructive sleep apnoea; awake hypoxaemia, hypercapnia or somnolence can indicate obesity hypoventilation.

Possible secondary driver

Cushingoid bruising and proximal weakness, hypothyroid symptoms, hypothalamic injury, rapid unexplained change or hypogonadal features justify targeted endocrine evaluation rather than a routine universal hormone panel.

Disordered eating

Binge episodes, purging, severe restriction, compulsive exercise, night eating, body-image distress or previous eating-disorder treatment should alter the intervention and may require specialist mental-health or dietetic care.

Weight stigma harm

Avoidance of care, previous humiliating encounters, poorly fitting equipment and every symptom being attributed to weight are clinically important barriers; acknowledge them and investigate new symptoms on their merits.

Baseline assessment

  1. 01
    Weight, height and BMIFirst step
    Why
    Provide a reproducible baseline for population risk and treatment eligibility.
    Interpretation and limitations
    Classify using adult thresholds while documenting situations that distort BMI; apply NICE's lower intervention thresholds for relevant ethnic backgrounds without changing how the person is respected.
  2. 02
    Waist circumference and waist-to-height ratio
    Why
    Estimate central adiposity when BMI alone may understate cardiometabolic risk.
    Interpretation and limitations
    For most adults with BMI below 35, waist at least half height indicates increased central risk; measurement adds less at very high BMI and must be performed consistently.
  3. 03
    Blood pressure and cardiovascular assessment
    Why
    Detect a common treatable complication and immediate vascular risk.
    Interpretation and limitations
    Confirm raised clinic readings through the NICE hypertension pathway; symptoms or severe pressure with organ injury require urgent assessment, not delayed lifestyle-only care.
  4. 04
    HbA1c or fasting plasma glucose
    Why
    Identify prediabetes, type 2 diabetes or marked hyperglycaemia.
    Interpretation and limitations
    Interpret using NICE diagnostic pathways and symptoms; very high glucose, ketones, dehydration or weight loss may indicate acute metabolic decompensation despite a high baseline weight.

Interventions

01First conversationOpen a respectful assessmentFirst stepWeight or central adiposity may be contributing to current health concerns.+
  1. 1Ask permission, agree neutral language, provide privacy and accessible equipment, and establish what the person hopes will improve rather than imposing a target.
  2. 2Measure BMI and central adiposity where useful, then assess medical complications, medicines, sleep, mental health, eating pattern, mobility and socioeconomic constraints.
  3. 3Share risk in plain language, agree whether the focus is prevention, symptom relief or disease treatment, and document options including no immediate weight-loss intervention.
02Behavioural planBuild a multicomponent interventionThe person chooses active non-pharmacological weight management.+
  1. 1Co-design nutritionally complete changes that create a tolerable energy deficit and fit culture, budget, cooking access, work pattern and any eating-disorder risk.

Targets, monitoring and follow-up

  • Use an agreed weighing frequency that informs care without reinforcing compulsive checking or shame; some people prefer functional and metabolic markers.
  • Review blood pressure, glycaemia, lipids, liver-risk pathway and sleep symptoms according to baseline abnormalities rather than repeating every test at each visit.
  • Track diet quality, protein and micronutrient adequacy when energy intake falls substantially, particularly in older adults and after previous bariatric surgery.
  • Screen for binge eating, restrictive compensation, low mood and suicidality when the intervention or body-image focus appears to worsen mental wellbeing.
  • Review medicines that promote weight gain and adjust only when the original indication, withdrawal risk and an effective alternative have been considered.
  • At maintenance visits, plan for relapse triggers, preserve physical activity and sleep routines, and offer prompt re-entry rather than requiring a new failure threshold.

Special situations

Permission changes the consultation

Asking whether now is a good time to discuss weight restores agency and often yields more honest information than beginning with an unsolicited instruction.

BMI needs a companion

Waist distribution, metabolic health, function and ethnicity can move risk in either direction, so a single ratio should open assessment rather than close it.

Health gains precede ideal weight

Small sustained changes can improve glycaemia, blood pressure, mobility and sleep; an unreachable cosmetic target can obscure meaningful clinical benefit.

Plateaux are biological

Energy expenditure and appetite adapt during loss. A plateau is a predictable treatment phase that prompts maintenance or escalation, not proof of dishonesty.

Equipment is patient safety

Suitable cuffs, scales, chairs, gowns, imaging limits and transfer aids are reasonable clinical requirements; missing equipment can delay diagnoses unrelated to obesity.

Common pitfalls

  1. 01

    Starting a sensitive weight conversation without permission or privacy.

  2. 02

    Using BMI as a verdict on individual behaviour or health.

  3. 03

    Attributing dyspnoea, pain or menstrual change to weight without ordinary diagnostic assessment.

  4. 04

    Prescribing a restrictive diet without screening for binge eating, malnutrition risk or food insecurity.

  5. 05

    Offering activity advice that ignores pain, disability, safety and current capacity.

  6. 06

    Repeating broad endocrine tests without clinical clues while missing sleep apnoea or medicines.

  7. 07

    Defining success only by scale change and abandoning cardiometabolic or functional gains.

  8. 08

    Treating regain as non-compliance rather than expected chronic-disease recurrence.

Practice

Two practice questions

Your practice draft is saved in this browser.

Question 1 of 2
0 correct
Endocrinology and metabolismOriginal SBA

Opening a weight discussion

During a diabetes review, a clinician thinks weight management may improve health. What is the most appropriate way to begin the conversation?

Choose one answer, then submit
← Rapid synopsisBack to overviewAll Endocrinology and metabolism topics →
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG246 overweight and obesity managementPerson-centred assessment, anthropometry, behavioural support and treatment escalation.
  • NICE PH49 behaviour change guidanceIndividual behaviour-change planning and maintenance principles.
  • NICE NG202 adult sleep apnoea guidanceRecognition and assessment of obstructive sleep apnoea and hypoventilation.
  • NICE NG238 cardiovascular risk recommendationsCardiovascular risk assessment and lipid management alongside weight care.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom
Set goals beyond kilograms, such as walking tolerance, glycaemia, blood pressure, sleep, pain, fertility planning and quality of life.
  • Expect plateaux and relapse because weight regulation is biological and environmental; review the plan without blame and escalate to medicines or surgery when indicated.
  • 05
    Non-fasting lipid profile
    Why
    Quantify atherosclerotic risk and screen severe triglyceride elevation.
    Interpretation and limitations
    Use total, HDL, non-HDL and triglycerides with overall cardiovascular risk; very high triglycerides need repeat fasting and urgent specialist logic rather than routine lifestyle review alone.
  • 06
    Liver blood tests and steatotic-liver fibrosis pathway
    Why
    Identify liver injury and people needing fibrosis risk assessment.
    Interpretation and limitations
    Normal transaminases do not exclude steatotic liver or fibrosis. Follow the local MASLD pathway rather than using one ALT result as reassurance.
  • 07
    Targeted TSH, cortisol or reproductive testing
    Why
    Investigate specific clinical evidence of endocrine or reproductive disease.
    Interpretation and limitations
    Request tests when symptoms and examination support them; indiscriminate cortisol panels and ovarian imaging can create false diagnoses without improving obesity care.
  • 08
    Validated sleep-apnoea assessment and oximetry pathway
    Why
    Triage symptoms toward respiratory sleep testing and treatment.
    Interpretation and limitations
    A questionnaire estimates probability but does not diagnose OSA; suspected awake hypoventilation needs blood gas and specialist respiratory assessment.
  • 2Increase physical activity and reduce sedentary time from the person's current ability, using physiotherapy or adapted exercise when pain, disability or cardiorespiratory disease limits movement.
  • 3Add sleep, stress, self-monitoring, problem-solving and social support, then schedule regular review with pre-agreed functional, metabolic and weight-related outcomes.
    • 03Plateau or regainReview without blameWeight loss plateaus, weight returns or the first plan proves unsustainable.+
    1. 1Reassess hunger, adherence burden, depression, binge eating, sleep, pain, new medicines, life events and whether the programme was realistically accessible.
    2. 2Preserve beneficial routines and cardiometabolic gains, then adjust intensity, dietetic support, activity adaptation or psychological intervention rather than prescribing shame.
    3. 3Discuss eligibility for licensed anti-obesity medicine or bariatric assessment through current NICE and local commissioning pathways when behavioural support alone is insufficient.
    04Complex riskEscalate multidisciplinary careEscalationSevere comorbidity, safeguarding, disordered eating or complex disability limits routine management.+
    1. 1Treat urgent respiratory, cardiovascular, glycaemic or psychiatric risk first and make reasonable adjustments so diagnostic care is not withheld because of size.
    2. 2Coordinate obesity medicine, dietetics, psychology, physiotherapy, respiratory, hepatology, diabetes or reproductive teams according to the complications actually present.
    3. 3Agree one accountable follow-up plan, including medicine review and crisis contacts, so multiple referrals do not leave the person without active care.